In the majority of cases, genomic alterations mainly comprised SVs, except for FGFR1 alterations in salivary gland carcinoma and FGFR2 alterations in cholangiocarcinoma, in which REs were most common (Figure 2). The gene discussed is FGFR1; the disease is salivary gland carcinoma.